Ortoma reported strong Q3 sales growth and a record US order, with positive EBITDA and a robust cash position. Regulatory progress and organizational strengthening support continued expansion.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.